BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17184987)

  • 1. Reconstituted expression of menin in Men1-deficient mouse Leydig tumour cells induces cell cycle arrest and apoptosis.
    Hussein N; Casse H; Fontanière S; Morera AM; Asensio MJ; Bakeli S; Lu JL; Coste I; Di Clemente N; Bertolino P; Zhang CX
    Eur J Cancer; 2007 Jan; 43(2):402-14. PubMed ID: 17184987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-beta pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice.
    Hussein N; Lu J; Casse H; Fontanière S; Morera AM; Guittot SM; Calender A; Di Clemente N; Zhang CX
    Endocr Relat Cancer; 2008 Mar; 15(1):217-27. PubMed ID: 18310289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menin molecular interactions: insights into normal functions and tumorigenesis.
    Agarwal SK; Kennedy PA; Scacheri PC; Novotny EA; Hickman AB; Cerrato A; Rice TS; Moore JB; Rao S; Ji Y; Mateo C; Libutti SK; Oliver B; Chandrasekharappa SC; Burns AL; Collins FS; Spiegel AM; Marx SJ
    Horm Metab Res; 2005 Jun; 37(6):369-74. PubMed ID: 16001329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEN1 missense mutations impair sensitization to apoptosis induced by wild-type menin in endocrine pancreatic tumor cells.
    Bazzi W; Renon M; Vercherat C; Hamze Z; Lacheretz-Bernigaud A; Wang H; Blanc M; Roche C; Calender A; Chayvialle JA; Scoazec JY; Cordier-Bussat M
    Gastroenterology; 2008 Nov; 135(5):1698-1709.e2. PubMed ID: 18775714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression and promoter methylation of the menin tumor suppressor in pancreatic ductal adenocarcinoma.
    Cavallari I; Silic-Benussi M; Rende F; Martines A; Fogar P; Basso D; Vella MD; Pedrazzoli S; Herman JG; Chieco-Bianchi L; Esposito G; Ciminale V; D'Agostino DM
    Genes Chromosomes Cancer; 2009 May; 48(5):383-96. PubMed ID: 19170121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple endocrine neoplasia type 1 interacts with forkhead transcription factor CHES1 in DNA damage response.
    Busygina V; Kottemann MC; Scott KL; Plon SE; Bale AE
    Cancer Res; 2006 Sep; 66(17):8397-403. PubMed ID: 16951149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple endocrine neoplasia type 1: a chromatin writer's block.
    Dreijerink KM; Lips CJ; Timmers HT
    J Intern Med; 2009 Jul; 266(1):53-9. PubMed ID: 19522825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patients.
    Luzi E; Marini F; Tognarini I; Carbonell Sala S; Galli G; Falchetti A; Brandi ML
    Cancer Gene Ther; 2010 Nov; 17(11):814-25. PubMed ID: 20706287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
    Dreijerink KM; Höppener JW; Timmers HM; Lips CJ
    Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.
    Chen G; A J; Wang M; Farley S; Lee LY; Lee LC; Sawicki MP
    Mol Cancer Res; 2008 Dec; 6(12):1894-907. PubMed ID: 19074834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases.
    Corbo V; Dalai I; Scardoni M; Barbi S; Beghelli S; Bersani S; Albarello L; Doglioni C; Schott C; Capelli P; Chilosi M; Boninsegna L; Becker KF; Falconi M; Scarpa A
    Endocr Relat Cancer; 2010 Sep; 17(3):771-83. PubMed ID: 20566584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEN1 mutation analysis in Chinese patients with multiple endocrine neoplasia type 1.
    Jiang XH; Lu JL; Cui B; Zhao YJ; Wang WQ; Liu JM; Fang WQ; Cao YN; Ge Y; Zhang CX; Casse H; Li XY; Ning G
    Endocr Relat Cancer; 2007 Dec; 14(4):1073-9. PubMed ID: 18045958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour suppressor menin is essential for development of the pancreatic endocrine cells.
    Fontanière S; Duvillié B; Scharfmann R; Carreira C; Wang ZQ; Zhang CX
    J Endocrinol; 2008 Nov; 199(2):287-98. PubMed ID: 18772165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p.Ala541Thr variant of MEN1 gene: a non deleterious polymorphism or a pathogenic mutation?
    Nozières C; Zhang CX; Buffet A; Dupasquier S; Vargas-Poussou R; Guillaud-Bataille M; Cordier-Bussat M; Ruszniewski P; Christin-Maitre S; Murat A; Groussin L; Vezzosi D; Cardot-Bauters C; Hervieu V; Joly MO; Giraud S; Odou MF; Gimenez-Roqueplo AP; Goudet P; Borson-Chazot F; Calender A;
    Ann Endocrinol (Paris); 2014 Jul; 75(3):133-40. PubMed ID: 24997771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable overexpression of MEN1 suppresses tumorigenicity of RAS.
    Kim YS; Burns AL; Goldsmith PK; Heppner C; Park SY; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ
    Oncogene; 1999 Oct; 18(43):5936-42. PubMed ID: 10557080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menin and its interacting proteins: elucidation of menin function.
    Balogh K; Rácz K; Patócs A; Hunyady L
    Trends Endocrinol Metab; 2006 Nov; 17(9):357-64. PubMed ID: 16997566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of vitamin D receptor function in MEN1-related parathyroid adenomas.
    Dreijerink KM; Varier RA; van Nuland R; Broekhuizen R; Valk GD; van der Wal JE; Lips CJ; Kummer JA; Timmers HT
    Mol Cell Endocrinol; 2009 Dec; 313(1-2):1-8. PubMed ID: 19729047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menin and TGF-beta superfamily member signaling via the Smad pathway in pituitary, parathyroid and osteoblast.
    Hendy GN; Kaji H; Sowa H; Lebrun JJ; Canaff L
    Horm Metab Res; 2005 Jun; 37(6):375-9. PubMed ID: 16001330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1.
    Bertolino P; Tong WM; Galendo D; Wang ZQ; Zhang CX
    Mol Endocrinol; 2003 Sep; 17(9):1880-92. PubMed ID: 12819299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability.
    Scacheri PC; Kennedy AL; Chin K; Miller MT; Hodgson JG; Gray JW; Marx SJ; Spiegel AM; Collins FS
    Cancer Res; 2004 Oct; 64(19):7039-44. PubMed ID: 15466197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.